Biodistribution and excretion of 153Gd-labeled gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid following repeated intravenous administration to rats
- 1 April 1995
- journal article
- Published by Elsevier in Academic Radiology
- Vol. 2 (4) , 313-318
- https://doi.org/10.1016/s1076-6332(05)80191-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Elimination of Gadolinium-Ethoxybenzyl-DTPA in a Rat Model of Severely Impaired Liver and Kidney Excretory FunctionInvestigative Radiology, 1994
- Complete elimination of the hepatobiliary mr contrast agent Gd-EOB-DTPA in hepatic dysfunction: An experimental study using transport-deficient, mutant ratsMagnetic Resonance Materials in Physics, Biology and Medicine, 1993
- Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience.Radiology, 1993
- Acute liver rejection: evaluation with cell-directed MR contrast agents in a rat transplantation model.Radiology, 1993
- Comparison of Gd‐EOB‐DTPA and Gd‐DTPA for contrast‐enhanced MR imaging of liver tumorsJournal of Magnetic Resonance Imaging, 1993
- Gadolinium-Ethoxybenzyl-DTPA, a New Liver-Directed Magnetic Resonance Contrast AgentInvestigative Radiology, 1993
- Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.Radiology, 1992
- Gadobenate dimeglumine--a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers.American Journal of Roentgenology, 1992
- Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.Radiology, 1992
- The relationship between thermodynamics and the toxicity of gadolinium complexesMagnetic Resonance Imaging, 1990